Ningbo David Medical Device Co., Ltd. (SHE:300314)
China · Delayed Price · Currency is CNY 9.51
-0.24 (-2.46%)
Jun 11, 2026, 3:04 PM CST
SHE:300314 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 74.37 | 87.05 | 57.26 | 147.61 | 97.36 | 80.21 |
Depreciation & Amortization | 24.23 | 24.23 | 26.72 | 27.32 | 25.51 | 24.55 |
Other Amortization | 5.33 | 5.33 | 3.56 | 0.09 | - | - |
Loss (Gain) From Sale of Assets | 0.39 | 0.39 | 0.01 | 0.23 | -0.02 | -0.12 |
Asset Writedown & Restructuring Costs | 0.02 | 0.02 | 0.53 | 1.61 | -0.88 | 1.95 |
Loss (Gain) From Sale of Investments | -15.31 | -15.31 | 10.06 | -11.59 | 5.78 | -15.99 |
Provision & Write-off of Bad Debts | 1.27 | 1.27 | 0.23 | 0.5 | 1.22 | - |
Other Operating Activities | 14.66 | 7.2 | 3.77 | -4.6 | -16.17 | 2.89 |
Change in Accounts Receivable | -25.97 | -25.97 | -2.03 | -9.05 | -5.6 | -3.14 |
Change in Inventory | -19 | -19 | -31.05 | -12.27 | -11.4 | -35.31 |
Change in Accounts Payable | 23.74 | 23.74 | 26.78 | -4.04 | 14.66 | -3.16 |
Operating Cash Flow | 84.03 | 89.25 | 93.87 | 135.2 | 111.57 | 51.48 |
Operating Cash Flow Growth | 16.78% | -4.92% | -30.57% | 21.18% | 116.72% | -62.62% |
Capital Expenditures | -41.82 | -55.03 | -139.69 | -40.39 | -49.78 | -6.53 |
Sale of Property, Plant & Equipment | 0.43 | 0.43 | 0.05 | 0.59 | 0.02 | 0.28 |
Investment in Securities | 131.41 | 131.41 | -130 | 107.5 | -2.5 | 93.5 |
Other Investing Activities | -2.29 | -26.34 | 7.03 | 4.06 | 11.41 | 19.44 |
Investing Cash Flow | 87.73 | 50.47 | -262.61 | 71.76 | -40.85 | 106.69 |
Long-Term Debt Repaid | - | -3.44 | -5.02 | -2.51 | -4.08 | -0.47 |
Net Debt Issued (Repaid) | -3.44 | -3.44 | -5.02 | -2.51 | -4.08 | -0.47 |
Common Dividends Paid | -25.06 | -25.06 | -51.84 | -43.2 | -28.8 | -43.2 |
Financing Cash Flow | -28.5 | -28.5 | -56.86 | -45.71 | -32.88 | -43.67 |
Foreign Exchange Rate Adjustments | -9.99 | -4.87 | -0.29 | 6.33 | 17.05 | -2.87 |
Net Cash Flow | 133.27 | 106.35 | -225.9 | 167.58 | 54.89 | 111.63 |
Free Cash Flow | 42.21 | 34.22 | -45.82 | 94.81 | 61.79 | 44.95 |
Free Cash Flow Growth | - | - | - | 53.43% | 37.48% | -60.41% |
Free Cash Flow Margin | 7.33% | 5.86% | -8.70% | 15.33% | 12.21% | 9.48% |
Free Cash Flow Per Share | 0.14 | 0.12 | -0.16 | 0.33 | 0.22 | 0.16 |
Cash Income Tax Paid | 22.59 | 20.85 | 22.12 | 56.96 | 34.82 | 33.17 |
Levered Free Cash Flow | 21.99 | -0.69 | -60.39 | 65.56 | 25.76 | 18.97 |
Unlevered Free Cash Flow | 22.02 | -0.42 | -60.09 | 65.93 | 25.97 | 18.99 |
Change in Working Capital | -20.94 | -20.94 | -8.28 | -25.97 | -1.23 | -42.02 |